Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors

dc.contributor.authorAzim, H. A., Jr.en
dc.contributor.authorPeccatori, F. A.en
dc.contributor.authorPavlidis, N.en
dc.date.accessioned2015-11-24T19:05:01Z
dc.date.available2015-11-24T19:05:01Z
dc.identifier.issn1532-1967-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/20131
dc.rightsDefault Licence-
dc.subjectAntineoplastic Agents/administration & dosage/*therapeutic useen
dc.subjectDose-Response Relationship, Drugen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectImmunosuppressive Agents/administration & dosage/*therapeutic useen
dc.subjectImmunotherapy/*methodsen
dc.subjectNeoplasms/*drug therapyen
dc.subjectPregnancyen
dc.subjectPregnancy Complications, Neoplastic/*drug therapyen
dc.subjectPregnancy Outcomeen
dc.subjectSelective Estrogen Receptor Modulators/administration & dosage/*therapeutic useen
dc.titleTreatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumorsen
heal.abstractThe association of cancer and pregnancy is increasingly encountered nowadays in clinical practice. Due to the relative rarity of the situation, it lacks a systematized approach. Different systemic therapies are used in managing cancer with uncertainty regarding the potential hazards they could pose on the pregnancy and/or the fetus. We have performed a systematic review of literature to identify all reports addressing cancer patients who were exposed to any of the known systemic therapies during the course of the pregnancy. The results were discussed in two parts; part I addresses pregnant patients with solid tumors while part I for those with hematological malignancies. In part I, we identified different solid tumors diagnosed and treated during the course of pregnancy. Breast cancer was the most commonly treated followed by ovarian cancer. Other tumors were treated as well including lung cancer, cervical cancer, sarcoma and melanomas. It is important to acknowledge the intent of therapy (palliative vs. curative) and the patients has to be properly counseled to reach an informed decision. We aim to provide a more robust consensus on how to approach these cases and provide a higher degree of evidence to support the safety of applying certain management strategies over the other.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1016/j.ctrv.2009.11.007-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/20015593-
heal.identifier.secondaryhttp://ac.els-cdn.com/S0305737209001819/1-s2.0-S0305737209001819-main.pdf?_tid=94865571e9d19575840a5da09eac4a8f&acdnat=1333609802_6adbd880a4f05ffb488180f92d0cbad3-
heal.journalNameCancer Treat Reven
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2010-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: